Search

Search Constraints

You searched for: Author/Creator Fuchs, O.

Search Results

1. High Level of Full-Length Cereblon Messenger RNA and Protein is Important for Lenalidomide Efficacy in Lower Risk MDS Patients. (April 2017)

2. MDS Patients with Del(5Q) and Trisomy 8 in Two Independent Clones Have High fli-1 and Cereblon Messenger RNA Levels. (April 2017)

3. Lenalidomide Treatment in Lower Risk MDS – The Experience of One Czech Center (Positive Effect of Erythropoietin ± Prednisone Addition). (April 2017)

4. Cytokine levels in children and adults with wheezing and asthma show specific patterns of variability over time. (15th December 2020)

6. 42 THE EFFICACY OF LENALIDOMIDE IN LOWER RISK MYELODYSPLASTIC SYNDROME WITH ISOLATED 5Q DELETION IS DEPENDENT ON HIGH LEVEL OF FULL-LENGTH CEREBLON MESSENGER RNA. (April 2015)

7. 106 PATIENTS WITH TWO UNRELATED CLONES DEL(5Q) AND TRISOMY 8 – A SUBTYPE OF 5Q- SYNDOME? UNCERTAIN PROGNOSIS OF PATIENTS WITH DECREASED DEL(5Q) CLONE DUE TO LENALIDOMIDE. Issue 1 (April 2015)